Sacituzumab govitecan is the active substance in Trodelvy. It consists of two active components: ● a monoclonal antibody which is a type of protein. It has been linked to a small molecule, SN-38. The monoclonal antibody has been designed in such a way it recognizes and attaches to Trop-2, a protein on numerous breast cancer cells. When it is attached, the medicine is used up by the cell, wherein SN-38 becomes active. ● SN-38 is a cancer drug that belongs to the group ‘topoisomerase inhibitors. It blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. By blocking the enzyme, cancer cells are not multiplied and die. By this mechanism of action, TRODELVY becomes a potent drug for breast cancer that is estrogen and progesterone hormone receptor (HR) negative, and human epidermal growth factor receptor 2 (HER2)-negative. To know more about the cost of TRODELVY injections, Call/WhatsApp at (+91) 8130290915 or visit https://theindianpharma.com/trodelvy-sacituzumab-govitecan-hziy/.